“…Concomitant interventions on the aortoiliac segment or the SFA were undertaken in 60% of patients. 13–15,18,26–28,31,33,35,39,40 Angioplasty alone was undertaken in 68.8% of treated patients. Angioplasty followed by selective or routine (three studies stenting was performed in 22.3% of patients.…”
Section: Resultsmentioning
confidence: 99%
“…12–40 Twenty of these reports were included after final review by the authors. 12–16,18,19,21,22,25–28,31,33,35–37,39,40 After reviewing the full paper, data regarding patient numbers and demographics, indications, pre- and post-intervention ankle-brachial index (ABI), site of intervention, and patency of SFA, technical success, type of endovascular approach, complications, patency and mortality rates were extracted and analyzed (Table 1). Figure 1.Flow diagram for inclusion and exclusion of relevant clinical reports.…”
Endovascular interventions to the common femoral artery and common femoral artery can be performed safely with high technical success. Endovascular therapy may be a favored approach over endarterectomy for highly selected patients of poor surgical risk, with limited life expectancy and those with wound-healing considerations such as re-operative fields or prone to infection.
“…Concomitant interventions on the aortoiliac segment or the SFA were undertaken in 60% of patients. 13–15,18,26–28,31,33,35,39,40 Angioplasty alone was undertaken in 68.8% of treated patients. Angioplasty followed by selective or routine (three studies stenting was performed in 22.3% of patients.…”
Section: Resultsmentioning
confidence: 99%
“…12–40 Twenty of these reports were included after final review by the authors. 12–16,18,19,21,22,25–28,31,33,35–37,39,40 After reviewing the full paper, data regarding patient numbers and demographics, indications, pre- and post-intervention ankle-brachial index (ABI), site of intervention, and patency of SFA, technical success, type of endovascular approach, complications, patency and mortality rates were extracted and analyzed (Table 1). Figure 1.Flow diagram for inclusion and exclusion of relevant clinical reports.…”
Endovascular interventions to the common femoral artery and common femoral artery can be performed safely with high technical success. Endovascular therapy may be a favored approach over endarterectomy for highly selected patients of poor surgical risk, with limited life expectancy and those with wound-healing considerations such as re-operative fields or prone to infection.
“…However, it has been confirmed that this collateral circulation plays an important role in chronic occlusions, when there has been sufficient time to allow their development. In the same way, Davies et al 12 compared the outcomes of endovascular PFA revascularization (ePFR) with ePFR and concurrent endovascular femoropopliteal revascularization. They reported 12-month amputation-free survival and reintervention rates of 78% and 72% following isolated ePFR, and 96% and 81% following ePFR and concurrent endovascular femoropopliteal revascularization, respectively.…”
The patency of the SFA does not interfere with the outcomes of endovascular treatment for chronic AIOD. The PFA in conjunction with the popliteal artery as the sole outflow route for iliac endovascular treatment is associated with similar patency, survival, and limb salvage rates as those for outflow through both the PFA and SFA.
“…19 The 12-month amputation-free survival and reintervention-free survival rates were 78% and 72%, respectively. 24 There are a number of limitations to our analysis. First, it is a self-reported retrospective study.…”
Endovascular interventions of the CFA/DFA have a low rate of periprocedural morbidity and mortality. One-year patency is lower than historically observed for CFA endarterectomy. Stent use is associated with reinterventions and amputation. Longer-term analysis is needed to better assess durability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
